Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive
TREM1-PET imaging of pro-inflammatory myeloid cells distinguishes active disease from remission in Multiple Sclerosis
Aisling Chaney, Edward Wilson, Poorva Jain, Haley Cropper, Michelle Swarovski, Katherine Lucot, Hannes Vogel, Katrin Andreasson and Michelle L. James
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 199;
Aisling Chaney
1Stanford University Stanford CA United States
Edward Wilson
1Stanford University Stanford CA United States
Poorva Jain
1Stanford University Stanford CA United States
Haley Cropper
1Stanford University Stanford CA United States
Michelle Swarovski
1Stanford University Stanford CA United States
Katherine Lucot
1Stanford University Stanford CA United States
Hannes Vogel
1Stanford University Stanford CA United States
Katrin Andreasson
1Stanford University Stanford CA United States
Michelle L. James
1Stanford University Stanford CA United States
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
TREM1-PET imaging of pro-inflammatory myeloid cells distinguishes active disease from remission in Multiple Sclerosis
Aisling Chaney, Edward Wilson, Poorva Jain, Haley Cropper, Michelle Swarovski, Katherine Lucot, Hannes Vogel, Katrin Andreasson, Michelle L. James
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 199;
TREM1-PET imaging of pro-inflammatory myeloid cells distinguishes active disease from remission in Multiple Sclerosis
Aisling Chaney, Edward Wilson, Poorva Jain, Haley Cropper, Michelle Swarovski, Katherine Lucot, Hannes Vogel, Katrin Andreasson, Michelle L. James
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 199;
Jump to section
Related Articles
- No related articles found.